<- Go Home
CanniMed Therapeutics Inc.
CanniMed Therapeutics Inc. operates as a biopharmaceutical company that specializes in the production and distribution of medical cannabis for pharmaceutical, agricultural, and environmental applications. It offers medical cannabis capsules, medical cannabis oils, dried medical cannabis, medical cannabis topicals, vaporizers, and vaporizer parts and accessories. CanniMed Therapeutics Inc. was formerly known as Prairie Plant Systems Inc. and changed its name to CanniMed Therapeutics Inc. in November 2016. The company was founded in 1988 and is based in Saskatoon, Canada. CanniMed Therapeutics Inc. operates as a subsidiary of Aurora Cannabis Inc.
Market Cap
CAD 682.0M
Volume
145.8K
Cash and Equivalents
CAD 42.3M
EBITDA
CAD 222.0K
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
CAD 13.6M
Profit Margin
74.93%
52 Week High
CAD 46.00
52 Week Low
CAD 7.32
Dividend
N/A
Price / Book Value
6.81
Price / Earnings
188.44
Price / Tangible Book Value
6.84
Enterprise Value
N/A
Enterprise Value / EBITDA
N/A
Operating Income
-CAD 2.0M
Return on Equity
3.46%
Return on Assets
-1.02
Cash and Short Term Investments
CAD 56.2M
Debt
CAD 12.4M
Equity
CAD 98.2M
Revenue
CAD 18.1M
Unlevered FCF
-CAD 6.0M
Sector
Pharmaceuticals
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium